LungLife AI

Company Profile

Company website
Pharmaceuticals and Biotechnology (Biotechnology)
LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence. The Company’s core technologies are integrated in the LungLB® test, which is intended to be used as a tool to provide physicians with additional information to help in the decision-making process for people with indeterminate lung nodules that may be lung cancer following a CT scan.

Investor Access

Event information

There is no Investor Access event planned at the moment - click on "Register your Interest" and we'll tell the Company that you'd like to attend one in the future and update you when an event is planned.

Financial Calendar
 Event Date
Year End31 December
Half  Year End30 June
Preliminary Results*September
Interim Results*March

* Months based on previous announcements of this kind